FDA has issued two Federal Register notices in under two weeks that seek comments on updates to FDA data standards.
Continue Reading FDA Requests Comments on Substantial Proposed Changes to Data Standards

Deepen Gagneja
Deepen Gagneja is an associate in the firm’s Washington, DC office where he is a member of the Food, Drug, and Device Practice Group. He advises pharmaceutical, biotechnology, device, and food companies on a variety of regulatory and compliance issues.